FI882912A - Laekemedelspreparat med finfoerdelade ebselen-kristaller. - Google Patents

Laekemedelspreparat med finfoerdelade ebselen-kristaller. Download PDF

Info

Publication number
FI882912A
FI882912A FI882912A FI882912A FI882912A FI 882912 A FI882912 A FI 882912A FI 882912 A FI882912 A FI 882912A FI 882912 A FI882912 A FI 882912A FI 882912 A FI882912 A FI 882912A
Authority
FI
Finland
Prior art keywords
ebselen
laekemedelspreparat
kristaller
finfoerdelade
med
Prior art date
Application number
FI882912A
Other languages
English (en)
Other versions
FI88256B (fi
FI882912A0 (fi
FI88256C (fi
Inventor
Axel Roemer
Juergen Seidel
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of FI882912A0 publication Critical patent/FI882912A0/fi
Publication of FI882912A publication Critical patent/FI882912A/fi
Publication of FI88256B publication Critical patent/FI88256B/fi
Application granted granted Critical
Publication of FI88256C publication Critical patent/FI88256C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12—Selenazoles; Hydrogenated selenazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI882912A 1987-06-20 1988-06-17 Foerfarande foer framstaellning av fasta laekemedelspreparat av 2-fenyl-1,2-bensisoselenazol-3(2h)-on (ebselen) FI88256C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3720493 1987-06-20
DE19873720493 DE3720493A1 (de) 1987-06-20 1987-06-20 Arzneizubereitungen mit mikronisierten ebselen-kristallen

Publications (4)

Publication Number Publication Date
FI882912A0 FI882912A0 (fi) 1988-06-17
FI882912A true FI882912A (fi) 1988-12-21
FI88256B FI88256B (fi) 1993-01-15
FI88256C FI88256C (fi) 1993-04-26

Family

ID=6330016

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882912A FI88256C (fi) 1987-06-20 1988-06-17 Foerfarande foer framstaellning av fasta laekemedelspreparat av 2-fenyl-1,2-bensisoselenazol-3(2h)-on (ebselen)

Country Status (25)

Country Link
US (1) US5021242A (fi)
EP (1) EP0296389B1 (fi)
JP (1) JPH0713016B2 (fi)
KR (1) KR970005322B1 (fi)
AT (1) ATE69165T1 (fi)
AU (1) AU603454B2 (fi)
CA (1) CA1310906C (fi)
DD (1) DD271056A5 (fi)
DE (2) DE3720493A1 (fi)
DK (1) DK173628B1 (fi)
ES (1) ES2041736T3 (fi)
FI (1) FI88256C (fi)
GE (1) GEP19960342B (fi)
GR (1) GR3003084T3 (fi)
HU (1) HU200096B (fi)
IE (1) IE63512B1 (fi)
LT (1) LT3669B (fi)
LV (1) LV10381B (fi)
MX (1) MX169170B (fi)
NO (1) NO175133C (fi)
NZ (1) NZ225066A (fi)
PT (1) PT87767B (fi)
RU (1) RU1834657C (fi)
UA (1) UA12648A (fi)
ZA (1) ZA884025B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP2553434B2 (ja) * 1992-04-28 1996-11-13 第一製薬株式会社 粒状製剤
ES2145065T3 (es) * 1993-10-27 2000-07-01 Daiichi Seiyaku Co Preparacion granular.
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
CN1090935C (zh) * 1995-02-28 2002-09-18 阿温蒂斯药物公司 哌啶子基烷醇化合物的药物组合物
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
AU3457300A (en) 1999-03-31 2000-10-16 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
EP1603867A2 (en) * 2003-02-24 2005-12-14 Mallinckrodt Inc. Process for preparing benzhydrylthioacetamide
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
WO2008148064A1 (en) * 2007-05-23 2008-12-04 Sunesis Pharmaceuticals, Inc. Weight loss treatment
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
TW201613888A (en) 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist
WO2022167778A1 (en) * 2021-02-02 2022-08-11 Haiku Therapeutics Ltd Ebselen as adenosine receptor modulator
WO2023240092A1 (en) * 2022-06-06 2023-12-14 Sound Pharmaceuticals Inc. Ebselen containing oral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen

Also Published As

Publication number Publication date
GEP19960342B (en) 1996-02-20
KR970005322B1 (ko) 1997-04-15
PT87767B (pt) 1992-10-30
ZA884025B (en) 1988-12-20
FI88256B (fi) 1993-01-15
MX169170B (es) 1993-06-23
CA1310906C (en) 1992-12-01
EP0296389A1 (de) 1988-12-28
EP0296389B1 (de) 1991-11-06
AU603454B2 (en) 1990-11-15
NO882615D0 (no) 1988-06-14
ATE69165T1 (de) 1991-11-15
LT3669B (en) 1996-01-25
NZ225066A (en) 1990-07-26
AU1811688A (en) 1988-12-22
LV10381A (lv) 1995-02-20
DK173628B1 (da) 2001-05-07
IE881628L (en) 1988-12-20
DK333388D0 (da) 1988-06-17
RU1834657C (ru) 1993-08-15
US5021242A (en) 1991-06-04
DK333388A (da) 1988-12-21
PT87767A (pt) 1989-05-31
FI882912A0 (fi) 1988-06-17
NO882615L (no) 1988-12-21
JPH01100125A (ja) 1989-04-18
KR890000084A (ko) 1989-03-11
DE3720493A1 (de) 1989-01-26
DD271056A5 (de) 1989-08-23
LV10381B (en) 1995-06-20
JPH0713016B2 (ja) 1995-02-15
LTIP903A (en) 1995-03-27
NO175133B (no) 1994-05-30
HUT50037A (en) 1989-12-28
NO175133C (no) 1994-09-07
GR3003084T3 (en) 1993-02-17
DE3866033D1 (de) 1991-12-12
FI88256C (fi) 1993-04-26
HU200096B (en) 1990-04-28
UA12648A (uk) 1997-02-28
ES2041736T3 (es) 1996-07-16
IE63512B1 (en) 1995-05-03

Similar Documents

Publication Publication Date Title
FI882912A0 (fi) Laekemedelspreparat med finfoerdelade ebselen-kristaller.
IS3156A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
SE8700499D0 (sv) Novel pharmacologically active compounds
NO853699L (no) Tetralinderivater, fremstilling og anvendelse derav.
NO884467D0 (no) Analogifremgangsmaate for fremstilling av aminomethyloxooxazolidinyl-ycloalkylbenzenderivater.
NO883506D0 (no) Fremgangsmaate for fremstilling av foretrede polyoksyalkylenderivater.
ES2032376T3 (es) Procedimiento para preparar 2-sustituidos-(amino-sustituidos)-n-arilalquil-3-(indol-3-il)propanimidas.
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DK324185A (da) 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
SE8404065D0 (sv) Novel biologically active compounds
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
ATE21248T1 (de) Derivate von 1h,3h-pyrrolo(1,2-c)thiazol, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
PT87550A (pt) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
DK243280A (da) 3,4,5-trihydroxypiperidinderivater deres fremstilling og anvendelse
IL61989A0 (en) Phenyl piperazine derivatives of 1,3,4-oxadiazolylphenols,their preparation and pharmaceutical compositions containing them
IT1164180B (it) Derivati n-carbammoilici dell'isotiazolo-(5,4b)piridin-one-3 e loro procedimento di preparazione
SE8306225D0 (sv) 2-piperazinyl-quinazoline derivatives, their production and pharmaceutical compositions containing them
DK313587D0 (da) Tetrahydrobenzothiazolforbindelser, deres fremstilling og anvendelse
ATE12241T1 (de) Leukotrienaehnliche verbindungen, deren herstellung und verwendung in pharmazeutischen zusammensetzungen.
FI882388A0 (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
DK176888D0 (da) Thieno-imidazo(2,1-b)thiazolderivater, fremgangsmaade til fremstilling af saadanne derivater og laegemiddel indeholdende disse
AU6740187A (en) Heterocyclic compounds, methods for the manufacture of the same and pharmaceutical compositions containing the same
ATE82973T1 (de) Aminosaeure-imid-derivate, ihre verwendung und diese enthaltende medizinische zusammensetzungen.
IT8867820A0 (it) Procedimento di preparazione di derivati dell'1,4-benzodiazepina-4-one

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: A. NATTERMANN & CIE GMBH